Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-09-22 17:43:45 UTC |
---|
HMDB ID | HMDB0000874 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Tauroursodeoxycholic acid |
---|
Description | Tauroursodeoxycholic acid is a bile acid also known as TUDCA formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. TUDCA is able to prevent apoptosis and protect mitochondria from cellular elements that would otherwise interfere with energy production. One of these elements is a protein called Bax. TUDCA plays an important role in preventing Bax from being transported to the mitochondria. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487 , 16037564 , 12576301 , 11907135 ). |
---|
Structure | [H][C@@]12CC[C@H]([C@H](C)CCC(=O)NCCS(O)(=O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)CC2C[C@H](O)CC[C@]12C InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17?,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1 |
---|
Synonyms | Value | Source |
---|
Tauroursodeoxycholate | Generator | 2-(((3-alpha,5-beta,7-beta)-3,7-Dihydroxy-24-oxocholan-24-yl) amino)ethanesulfonate | HMDB | 2-(((3-alpha,5-beta,7-beta)-3,7-Dihydroxy-24-oxocholan-24-yl) amino)ethanesulfonic acid | HMDB | 2-(((3-alpha,5-beta,7-beta)-3,7-Dihydroxy-24-oxocholan-24-yl)amino)-ethanesulfonate | HMDB | 2-(((3-alpha,5-beta,7-beta)-3,7-Dihydroxy-24-oxocholan-24-yl)amino)-ethanesulfonic acid | HMDB | 3a,7b-Dihydroxy-5b-cholanoyltaurine | HMDB | N-(3-alpha,7-beta-Dihydroxy-5-beta-cholan-24-oyl)-taurine | HMDB | TUDCA | HMDB | UR 906 | HMDB | Ursodeoxycholyltaurine | HMDB | Tauroursodeoxycholic acid, monosodium salt, (3alpha,5beta,7alpha)-isomer | HMDB | Tauroursodeoxycholic acid, (3alpha,5alpha,7alpha)-isomer | HMDB | Tauroursodeoxycholic acid, monosodium salt, (3alpha,7alpha)-isomer | HMDB | (4R)-4-[(1S,2S,5R,9S,10R,11S,14R,15R)-5,9-Dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]-N-(2-sulfoethyl)pentanimidate | HMDB | (4R)-4-[(1S,2S,5R,9S,10R,11S,14R,15R)-5,9-Dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]-N-(2-sulphoethyl)pentanimidate | HMDB | (4R)-4-[(1S,2S,5R,9S,10R,11S,14R,15R)-5,9-Dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]-N-(2-sulphoethyl)pentanimidic acid | HMDB |
|
---|
Chemical Formula | C26H45NO6S |
---|
Average Molecular Weight | 499.704 |
---|
Monoisotopic Molecular Weight | 499.296758867 |
---|
IUPAC Name | 2-[(4R)-4-[(1S,2S,5R,9S,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid |
---|
Traditional Name | 2-[(4R)-4-[(1S,2S,5R,9S,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanamido]ethanesulfonic acid |
---|
CAS Registry Number | 14605-22-2 |
---|
SMILES | [H][C@@]12CC[C@H]([C@H](C)CCC(=O)NCCS(O)(=O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)CC2C[C@H](O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17?,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1 |
---|
InChI Key | BHTRKEVKTKCXOH-VSHSPWMTSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Bile acids, alcohols and derivatives |
---|
Direct Parent | Taurinated bile acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Taurinated bile acid
- Dihydroxy bile acid, alcohol, or derivatives
- Hydroxy bile acid, alcohol, or derivatives
- 3-hydroxysteroid
- Hydroxysteroid
- 3-alpha-hydroxysteroid
- 7-alpha-hydroxysteroid
- 7-hydroxysteroid
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Sulfonyl
- Organosulfonic acid
- Organosulfonic acid or derivatives
- Organic sulfonic acid or derivatives
- Alkanesulfonic acid
- Cyclic alcohol
- Secondary carboxylic acid amide
- Secondary alcohol
- Carboxamide group
- Carboxylic acid derivative
- Organic oxide
- Organopnictogen compound
- Organic nitrogen compound
- Organic oxygen compound
- Organonitrogen compound
- Organosulfur compound
- Organooxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Tauroursodeoxycholic acid,1TMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4179.8 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,1TMS,isomer #2 | C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4297.9 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,1TMS,isomer #3 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4348.3 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,1TMS,isomer #4 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4270.8 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4132.9 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TMS,isomer #2 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4209.7 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TMS,isomer #3 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4104.5 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TMS,isomer #4 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4353.5 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TMS,isomer #5 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4271.9 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TMS,isomer #6 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4339.3 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4167.4 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4435.2 | Standard non polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4852.2 | Standard polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #2 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4052.2 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #2 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4504.2 | Standard non polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #2 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4917.0 | Standard polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #3 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4151.1 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #3 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4542.1 | Standard non polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #3 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4888.9 | Standard polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #4 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4283.6 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #4 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4519.8 | Standard non polar | 33892256 | Tauroursodeoxycholic acid,3TMS,isomer #4 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4876.7 | Standard polar | 33892256 | Tauroursodeoxycholic acid,4TMS,isomer #1 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4124.8 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,4TMS,isomer #1 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4645.0 | Standard non polar | 33892256 | Tauroursodeoxycholic acid,4TMS,isomer #1 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C)[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C)CC4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4678.3 | Standard polar | 33892256 | Tauroursodeoxycholic acid,1TBDMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4371.3 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,1TBDMS,isomer #2 | C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4497.3 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,1TBDMS,isomer #3 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4532.5 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,1TBDMS,isomer #4 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4527.9 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TBDMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4513.4 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TBDMS,isomer #2 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4582.2 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TBDMS,isomer #3 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4554.0 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TBDMS,isomer #4 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4758.0 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TBDMS,isomer #5 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4715.8 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,2TBDMS,isomer #6 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4791.8 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4742.0 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 5214.2 | Standard non polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #1 | C[C@H](CCC(=O)NCCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4939.8 | Standard polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #2 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4703.8 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #2 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 5223.0 | Standard non polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #2 | C[C@H](CCC(=O)N(CCS(=O)(=O)O)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 5010.2 | Standard polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #3 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4780.7 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #3 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 5325.9 | Standard non polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #3 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O[Si](C)(C)C(C)(C)C)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 4988.3 | Standard polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #4 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4932.6 | Semi standard non polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #4 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 5296.9 | Standard non polar | 33892256 | Tauroursodeoxycholic acid,3TBDMS,isomer #4 | C[C@H](CCC(=O)N(CCS(=O)(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)CC4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C | 4968.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-053r-0212900000-14bc097af3f7499753d7 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (2 TMS) - 70eV, Positive | splash10-004i-4214259000-4a72734ef61b01c2f556 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_2_5) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tauroursodeoxycholic acid GC-MS (TBDMS_2_6) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 10V, Positive-QTOF | splash10-00e9-0801920000-ecfc97935416325b3ca5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 20V, Positive-QTOF | splash10-00di-2901100000-9a3cf7f2963c041be363 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 40V, Positive-QTOF | splash10-006x-8904100000-98cfa2606dbba4ef47a0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 10V, Negative-QTOF | splash10-000t-2001900000-4adf0e40de3812e8d0ba | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 20V, Negative-QTOF | splash10-001i-6404900000-4d05b6f0352aebf4228d | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 40V, Negative-QTOF | splash10-001l-9102000000-63892e6e06f1123f8bfc | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 10V, Negative-QTOF | splash10-0002-0000900000-31f17d1d48b7afdf3bae | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 20V, Negative-QTOF | splash10-0002-0000900000-f4f03ef481870394f9e2 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 40V, Negative-QTOF | splash10-001i-9100300000-654e1207ef97c7662b6e | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 10V, Positive-QTOF | splash10-0gx0-0000940000-9827b7f4a5b2f54a7bd4 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 20V, Positive-QTOF | splash10-0nmi-4639730000-a8491d87ed7e9a353ee5 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tauroursodeoxycholic acid 40V, Positive-QTOF | splash10-0f7x-3893000000-cc5d0b26da084a4d3a35 | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|
General References | - Rolo AP, Palmeira CM, Holy JM, Wallace KB: Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis. Toxicol Sci. 2004 May;79(1):196-204. Epub 2004 Feb 19. [PubMed:14976352 ]
- Tessier E, Neirinck L, Zhu Z: High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 25;798(2):295-302. [PubMed:14643509 ]
- Yamaguchi Y, Itami S, Nishida K, Ando Y, Okamoto S, Hosokawa K, Yoshikawa K: Taurin-conjugated ursodeoxycholic acid has a reversible inhibitory effect on human keratinocyte growth. J Dermatol Sci. 1998 Sep;18(1):35-42. [PubMed:9747660 ]
- Shekels LL, Beste JE, Ho SB: Tauroursodeoxycholic acid protects in vitro models of human colonic cancer cells from cytotoxic effects of hydrophobic bile acids. J Lab Clin Med. 1996 Jan;127(1):57-66. [PubMed:8592097 ]
- Lee DK, Park SY, Baik SK, Kwon SO, Chung JM, Oh ES, Kim HS: [Deoxycholic acid-induced signal transduction in HT-29 cells: role of NF-kappa B and interleukin-8]. Korean J Gastroenterol. 2004 Mar;43(3):176-85. [PubMed:15034288 ]
- Cai W, Khaoustov VI, Xie Q, Pan T, Le W, Yoffe B: Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. J Hepatol. 2005 Jun;42(6):880-7. Epub 2005 Apr 7. [PubMed:15885359 ]
- Loria P, Bozzoli M, Concari M, Guicciardi ME, Carubbi F, Bertolotti M, Piani D, Nistri A, Angelico M, Romani M, Carulli N: Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans. Hepatology. 1997 Jun;25(6):1306-14. [PubMed:9185744 ]
- Henzel K, Thorborg C, Hofmann M, Zimmer G, Leuschner U: Toxicity of ethanol and acetaldehyde in hepatocytes treated with ursodeoxycholic or tauroursodeoxycholic acid. Biochim Biophys Acta. 2004 Feb 2;1644(1):37-45. [PubMed:14741743 ]
- St-Pierre MV, Kullak-Ublick GA, Hagenbuch B, Meier PJ: Transport of bile acids in hepatic and non-hepatic tissues. J Exp Biol. 2001 May;204(Pt 10):1673-86. [PubMed:11316487 ]
- Claudel T, Staels B, Kuipers F: The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2020-30. Epub 2005 Jul 21. [PubMed:16037564 ]
- Chiang JY: Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol. 2003 Mar;284(3):G349-56. [PubMed:12576301 ]
- Davis RA, Miyake JH, Hui TY, Spann NJ: Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP. J Lipid Res. 2002 Apr;43(4):533-43. [PubMed:11907135 ]
|
---|